Brock, Rosalind Rowse, Georgina and Slade, Pauline 2016. Relationships between paranoid thinking, self-esteem and the menstrual cycle. Archives of Women's Mental Health, Vol. 19, Issue. 2, p. 271.
Chua, Wan Lian LC Grigorov, Hristo S Hiley, John and Chua, Wan Lian LC 2016. Cochrane Database of Systematic Reviews.
Crider, A. and Pillai, A. 2016. Estrogen Signaling as a Therapeutic Target in Neurodevelopmental Disorders. Journal of Pharmacology and Experimental Therapeutics, Vol. 360, Issue. 1, p. 48.
Doğan Bulut, Süheyla Bulut, Serdar and Güriz, Olga 2016. The relationship between sex hormone profiles and symptoms of schizophrenia in men. Comprehensive Psychiatry, Vol. 69, p. 186.
Gleeson, Pia C Worsley, Roisin Gavrilidis, Emorfia Nathoo, Shainal Ng, Elisabeth Lee, Stuart and Kulkarni, Jayashri 2016. Menstrual cycle characteristics in women with persistent schizophrenia. Australian & New Zealand Journal of Psychiatry, Vol. 50, Issue. 5, p. 481.
Patrich, Eti Piontkewitz, Yael Peretz, Asher Weiner, Ina and Attali, Bernard 2016. Maturation- and sex-sensitive depression of hippocampal excitatory transmission in a rat schizophrenia model. Brain, Behavior, and Immunity, Vol. 51, p. 240.
Sun, Jeehae Walker, Adam J. Dean, Brian van den Buuse, Maarten and Gogos, Andrea 2016. Progesterone: The neglected hormone in schizophrenia? A focus on progesterone-dopamine interactions. Psychoneuroendocrinology, Vol. 74, p. 126.
Chase, Kayla A. Rosen, Cherise Rubin, Leah H. Feiner, Benjamin Bodapati, Anjuli S. Gin, Hannah Hu, Edward and Sharma, Rajiv P. 2015. Evidence of a sex-dependent restrictive epigenome in schizophrenia. Journal of Psychiatric Research, Vol. 65, p. 87.
da Silva, Tricia L. and Ravindran, Arun V. 2015. Contribution of sex hormones to gender differences in schizophrenia: A review. Asian Journal of Psychiatry, Vol. 18, p. 2.
Gogos, Andrea Sbisa, Alyssa M. Sun, Jeehae Gibbons, Andrew Udawela, Madhara and Dean, Brian 2015. A Role for Estrogen in Schizophrenia: Clinical and Preclinical Findings. International Journal of Endocrinology, Vol. 2015, p. 1.
González-Rodríguez, Alexandre Molina-Andreu, Oriol Penadés Rubio, Rafael Catalán Campos, Rosa and Bernardo Arroyo, Miguel 2015. Reproductive variables and gynaecological service use in delusional disorder outpatients. Revista de Psiquiatría y Salud Mental (English Edition), Vol. 8, Issue. 2, p. 92.
González-Rodríguez, Alexandre Molina-Andreu, Oriol Penadés Rubio, Rafael Catalán Campos, Rosa and Bernardo Arroyo, Miguel 2015. Variables reproductivas y uso de consulta ginecológica en pacientes con trastorno delirante. Revista de Psiquiatría y Salud Mental, Vol. 8, Issue. 2, p. 92.
González-Rodríguez, Alexandre Molina-Andreu, Oriol Penadés, Rafael Garriga, Marina Pons, Alexandre Catalán, Rosa and Bernardo, Miguel 2015. Delusional Disorder over the Reproductive Life Span: The Potential Influence of Menopause on the Clinical Course. Schizophrenia Research and Treatment, Vol. 2015, p. 1.
Heringa, Sophie M. Begemann, Marieke J.H. Goverde, Angelique J. and Sommer, Iris E.C. 2015. Sex hormones and oxytocin augmentation strategies in schizophrenia: A quantitative review. Schizophrenia Research, Vol. 168, Issue. 3, p. 603.
Kulkarni, J Gavrilidis, E Wang, W Worsley, R Fitzgerald, P B Gurvich, C Van Rheenen, T Berk, M and Burger, H 2015. Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age. Molecular Psychiatry, Vol. 20, Issue. 6, p. 695.
Mahmoud, Rand and Galea, Liisa A.M. 2015. International Encyclopedia of the Social & Behavioral Sciences.
Seeman, Mary V. 2015. Transient psychosis in women on clomiphene, bromocriptine, domperidone and related endocrine drugs. Gynecological Endocrinology, Vol. 31, Issue. 10, p. 751.
Donoghue, Kim Doody, Gillian A. Murray, Robin M. Jones, Peter B. Morgan, Craig Dazzan, Paola Hart, Jozella Mazzoncini, Rodolfo and MacCabe, James H. 2014. Cannabis use, gender and age of onset of schizophrenia: Data from the ÆSOP study. Psychiatry Research, Vol. 215, Issue. 3, p. 528.
Godar, Sean C. and Bortolato, Marco 2014. Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission. Frontiers in Behavioral Neuroscience, Vol. 8,
Perez, Stephanie M. Chen, Li and Lodge, Daniel J. 2014. Alterations in dopamine system function across the estrous cycle of the MAM rodent model of schizophrenia. Psychoneuroendocrinology, Vol. 47, p. 88.
Estrogen has been hypothesized to have a protective and antipsychotic-like effect in women at risk for schizophrenia. The aim of the present study was to evaluate the association between menstrual cycle and/or estrogen levels and psychotic symptoms in a sample of women with schizophrenia.
One hundred and twenty-five premenopausal women with schizophrenia and regular menses were examined. The levels of 17β-estradiol and other hormones of the gonadal axis were assessed in the follicular, peri-ovulatory, and luteal phases of the menstrual cycle. The effects of the menstrual cycle phase and/or the estradiol level on the Positive and Negative Syndrome Scale (PANSS) and the Brief Psychiatric Rating Scale (BPRS) scores were calculated by means of regression analyses.
Significant improvement in psychotic, but not depressive, symptoms was observed during the luteal phase, compared with other days of the menstrual cycle.
The present findings indicate that estradiol may have specific antipsychotic-like effects on the symptoms of schizophrenia. Thus further investigation into the therapeutic effect of estrogen may be worthwhile.
This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.
Full text views reflects the number of PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.
Abstract views reflect the number of visits to the article landing page.
* Views captured on Cambridge Core between September 2016 - 24th March 2017. This data will be updated every 24 hours.